Loading clinical trials...
Loading clinical trials...
Phase 1/2a Dose-ranging, Safety, Pharmacokinetics, and Preliminary Efficacy Study of MPB-1734 in Patients With Advanced Solid Tumors in Part 1 and With Selected Solid Tumors in Part 2
Conditions
Interventions
MPB-1734
Locations
1
Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan
Start Date
March 8, 2022
Primary Completion Date
March 31, 2025
Completion Date
December 1, 2025
Last Updated
November 3, 2025
NCT06911333
NCT06883539
NCT06895681
NCT04976803
Lead Sponsor
MegaPro Biomedical Co. Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions